Table 3

Baseline comparison of intervention group (n=73) with control group (n=69)

CharacteristicIntervention group (n=73)Control group (n=69)
Mean age (SD) (years)66.6 (11.5)65.9 (10.8)
Malen=33 (45.2%)n=44 (63.8%)
Histology of lesion
 BCCn=55 (75.3%)n=52 (75.4%)
 SCCn=7 (9.6%)n=8 (11.6%)
 IECn=10 (13.7%)n=9 (13.0%)
 Dysplastic naevusn=1 (1.4%)n=0
Body site of lesion
 Nosen=55 (75.3%)n=45 (65.2%)
 Earn=18 (24.7%)n=24 (34.8%)
Smokern=4 (5.5%)n=6 (8.7%)
Diabetes mellitusn=8 (11.0%)n=8 (11.6%)
Anticoagulant medicationn=19 (26.0%)n=17 (24.6%)
Immunosuppressive medicationn=1 (1.4%)n=1 (1.4%)
Median time to surgery (IQR) (min)50 (45–55)50 (45–55)
Modified MMS*n=10 (13.7%)n=12 (17.4%)
Surgical repair technique
 Flap repairn=68 (94.5%)n=58 (88.4%)
 Skin graftn=3 (4.1%)n=6 (8.7%)
 Wedge excisionn=1 (1.4%)n = 2 (2.9%)
Median defect size (IQR); range (mm)13 (11.5–16); 9–2514 (12–16.5); 9–30
  • *Delayed surgical closure awaiting complete histological margin analysis.

  • MMS, Mohs micrographic surgery.